Cell-based Assays Market by Product and Service (Consumables, Instruments, Services); Application (Drug Discovery, Basic Research, Other Applications) and End User (Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00027028 | Pages: 100 | Industry: Medical Device | Date: Oct 2022 | Type: Global

The market crossed US$ 21.21 billion mark in 2022 and is expected to hit US$ 34.62 billion by 2030, recording a CAGR of 6.6% during the forecast period.

Consumables segment held the largest share by product segment.

Based on the product, the Cell-based Assays Market  is segmented into consumables, instruments, and services. The consumables segment held the largest share in 2022 and it is also anticipated to grow at highest CAGR during the forecast period. The growth of the segment can be attributed to the growing number of drug discovery activities across the globe.

Within the report, the market is segmented into product and service, application, end user, geography. By product and service, the market is further segmented into consumables, instruments, and services. By application the market is segmented into drug discovery, basic research, other applications. On the basis of end-user the market is segmented  into pharmaceutical & biotechnology companies, academic & government institutes, contract research organizations. Geographically, the market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report :

Increasing Drug Discoveries and Approvals is likely to drive the market growth

Researchers across the globe are continuously working towards discovering next generation drugs to treat health threats in 21st century. Over the past decade, the pharmaceutical industry has discovered increasing number of drugs annually. Between the period 2010 and 2019, around 38 new drugs were approved each year, on average. In the year 2021, the Center for Drug Evaluation and Research (CDER) approved about 50 novel therapeutics.

Thus, growing medical applications of cryogenic equipments is likely to drive the growth of the market.

Growing Biotechnology & Biopharmaceutical Industries is likely to create growth opportunities for the market.

In recent years, the biotechnology industry is developing at an extraordinarily rapid speed. Manufacturers are confronting to the various healthcare difficulties through the latest medicines, progressing digitalization, therapy forms, and continuously changing the management. Also, the biotechnology sector in Germany has witnessed significant growth during the year 2017, with the investments made by the companies reaching up to US$ 756.03 Mn (i.e., €674 million).

Recent strategic developments in Cell-based Assays Market  

The Cell-based Assays Market has undergone several significant developments, and a few of these have been mentioned below:

  • In 2020, Danaher Corporation, introduced ImageXpress Micro-confocal High-content Imaging System.
  • In 2020, Charles River Laboratories signed a drug discovery collaboration with Karuna Therapeutics, a US-based CRO, to expand its drug discovery capabilities.

The cell-based assays market  is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, General Electric Company, Merck KGaA, Lonza Group Ltd, Perkinelmer, Inc., Charles River Laboratories, Inc., Cell Signaling Technology, Inc. and Promega Corporation are among the prominent players operating in the market.

Target audience for the report:

  • Manufacturing Companies
  • Government & Research Organizations
  • Organizations, Forums, Alliances & Associations
  • State & National Energy Authorities
  • Dealers & Suppliers And Vendors

 

 

Scope of the report:

In this report, the market has been segmented on the basis of:

 

  • Service
    • Consumables
    • Instruments
    • Services
  • Application
    • Drug Discovery
    • Basic Research
    • Other Applications
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    •   Thermo Fisher Scientific Inc.
    •   Danaher Corporation
    •   Becton, Dickinson and Company
    •   General Electric Company
    •   Merck KGaA
    •   Lonza Group Ltd.
    •   Perkinelmer, Inc.
    •   Charles River Laboratories, Inc.
    •   Cell Signaling Technology, Inc.
    •   Promega Corporation

The List of Companies
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Becton, Dickinson and Company
- General Electric Company
- Merck KGaA
- Lonza Group Ltd.
- Perkinelmer, Inc.
- Charles River Laboratories, Inc.
- Cell Signaling Technology, Inc.
- Promega Corporation

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$1500
Site License
$2500
Enterprise License
$3500